Table: Kringle Pharma -2025/26 parent forecast

Kringle Pharma

11/03/2026 05:15

Mar 11 (Reuters) -
              Kringle Pharma, Inc.     
              PARENT- ONLY EARNINGS ESTIMATES
  (in billions of yen unless specified)                    
                 Full Year to      Full Year to 
               Sep 30, 2026      Sep 30, 2026   
                  LATEST           PREVIOUS     
                 FORECAST          FORECAST     
  Sales           332 mln           72 mln      
  Operating      loss 1.02         loss 1.17    
  Recurring      loss 1.02         loss 1.17    
  Net            loss 1.02         loss 1.17    
  EPS         loss 139.85 yen   loss 167.21 yen 
 
  NOTE - Kringle Pharma, Inc..    
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T